I am a
Home I AM A Search Login

Papers of the Week


Papers: 30 May 2020 - 5 Jun 2020


Human Studies, Pharmacology/Drug Development

PAIN TYPE:
Migraine/Headache


2020 Jun 01


J Headache Pain


21


1

A prospective real-world analysis of erenumab in refractory chronic migraine.

Authors

Lambru G, Hill B, Murphy M, Tylova I, Andreou AP
J Headache Pain. 2020 Jun 01; 21(1):61.
PMID: 32487102.

Abstract

Clinical trials have shown the safety and clinical superiority of erenumab compared to placebo in chronic migraine (CM). The aim of this analysis is to evaluate the effectiveness and tolerability of erenumab in a real-world setting in patients with refractory CM.